Skip to main content
. 2015 Jan 27;290(11):6837–6843. doi: 10.1074/jbc.M114.622670

TABLE 1.

Patient characteristics

BMI, body mass index; DM, diabetes mellitus; IFG, impaired fasting glucose; LVEF, left ventricular ejection fraction; HbA1c, hemoglobin A1c.

Pro-CCK
p value
Total (n = 186) <17.75 pm (n = 93) ≥17.75 pm (n = 93)
Demographics
    Age (years)a 69.3 ± 10.4 66.2 ± 10.5 72.3 ± 9.4 0.122
    Females/males (n) 54/132 22/71 32/61 0.106
    BMI (kg/m2)a 27.1 ± 5.0 28.3 ± 5.1 25.8 ± 4.6 0.495

Cardiovascular disease (n)
    Nonischemic heart disease 78 41 37 0.506
    Ischemic heart disease 103 49 54
    Missing 5 3 2

Diabetic status (n)
    Nondiabetic 119 55 64 0.532
    DM history 38 21 17
    DM newly diagnosed 8 6 2
    IFG 14 7 7
    Not classified 7 4 3

Heart failure measurementsa
    LVEF (%) 30.3 ± 8.3 30.0 ± 8.2 30.5 ± 8.4 0.600
    Heart rate (beats/min) 74.6 ± 15.2 75.8 ± 13.8 73.3 ± 16.5 0.022
    Diastolic blood pressure (mm Hg) 78.5 ± 14.4 80.5 ± 14.4 76.4 ± 14.5 0.526
    Systolic blood pressure (mm Hg) 138.6 ± 25.2 138.3 ± 23.3 138.9 ± 27.7 0.272
    6-min walk test (m) 367.9 ± 143.9 382.8 ± 135.7 346.3 ± 83.1 0.392

Metabolic status
    Fasting insulin (pmol/liter)b 82.8 84.4 81.4 0.636
    HbA1c (%)a 6.2 ± 1.3 6.28 ± 1.4 6.17 ± 1.1 0.116
    Cholesterol (mm)a 5.2 ± 1.3 5.1 ± 1.1 5.2 ± 1.5 0.074
    Creatinine (μm)a 100 ± 32.1 95.2 ± 28.0 105.3 ± 36.0 0.333
    Fasting blood glucose (mm)a 5.7 ± 2.3 5.8 ± 2.5 5.6 ± 2.1 0.238

a Values are expressed as mean ± S.D.

b Values are expressed as the median.